Testosterone Science

Media Watch

Testosterone for Women UK: Menopause, Cost and Where to Get It (2026)

Specific Claim Evaluated

Testosterone is prescribed as part of menopausal HRT mainly for low libido, fatigue and brain fog, in line with British Menopause Society guidance, and side effects such as acne, facial hair growth and voice deepening are rare when properly dosed and monitored.

Primary Research Supporting or Contradicting the Claim

Randomized trials at physiologic doses show more acne and hair growth with testosterone than placebo (Islam et al., 2019). Evidence is insufficient to establish an effect on cognition (Faulkner et al., 2026), and the only evidence-based indication is hypoactive sexual desire disorder (Davis et al., 2019).

Corrected Evidence-Based Interpretation

UK guidance supports testosterone for low sexual desire after HRT optimization. It is not indicated for fatigue or brain fog, and androgenic adverse effects are more common than with placebo even at physiologic doses.

Rationale for Grade

The page cites guidance limited to low sexual desire but presents fatigue and brain fog as main indications, and it describes androgenic adverse effects as rare without evidence. Both statements misrepresent the sources they rely on.

References

  1. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
    Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD."
  2. Faulkner A, Desai R, Keay N, Ellahi SA, Spector A. Testosterone therapy for cognition in menopause: a systematic review and meta-analysis. Reprod Fertil. 2026;7(4). PMID
    Supporting excerpt: "insufficient to establish an effect rather than as evidence of no effect"
  3. Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754-766. PMID
    Supporting excerpt: "Testosterone is effective for postmenopausal women with low sexual desire causing distress"

Post a Comment

Shared Decision Making

Bring the Evidence to Your Next Consultation

Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.